Literature DB >> 21849790

Modifiers and subtype-specific analyses in whole-genome association studies: a likelihood framework.

Phil H Lee1, Sarah E Bergen, Roy H Perlis, Patrick F Sullivan, Pamela Sklar, Jordan W Smoller, Shaun M Purcell.   

Abstract

OBJECTIVE: We propose new statistical methods for analyzing genetic case/control association data in which cases can be further classified into subtypes, for example, based on clinical features. The primary utility of our work is the ability to distinguish between subtype-specific and modifier effects of genetic variants within a single testing framework.
METHODS: A range of disease/subtype causal models are defined for genetic variants involving subtype-specific and modifier effects. We present a log-linear modeling framework enabling comparison between these causal models and selection of the best-fit model.
RESULTS: We evaluate and compare the analytic power and model selection performance of the proposed work with standard two-group-based association tests. Simulation studies demonstrate that our approach has similar or greater power than the traditional approach over a range of causal models. We also report empirical findings about the impact of misspecification of subtype frequency during model selection, and extend the application of the proposed work to the cross-disorder association studies of multiple diseases.
CONCLUSION: Whether a variant is a disease risk factor, is subtype specific, or modifies disease features has important consequences for the interpretation and follow-up of genetic associations. Our framework provides a simple, systematic way to evaluate and describe associations involving such subtype-specific or modifier effects.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21849790      PMCID: PMC7077092          DOI: 10.1159/000327158

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  21 in total

Review 1.  Is treatment-resistant depression a unique subtype of depression?

Authors:  Andrea Fagiolini; David J Kupfer
Journal:  Biol Psychiatry       Date:  2003-04-15       Impact factor: 13.382

2.  Further evidence for a developmental subtype of bipolar disorder defined by age at onset: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Benjamin I Goldstein; Anthony J Levitt
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

3.  Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.

Authors:  Jie Huang; Roy H Perlis; Phil H Lee; A John Rush; Maurizio Fava; Gary S Sachs; Jeffrey Lieberman; Steven P Hamilton; Patrick Sullivan; Pamela Sklar; Shaun Purcell; Jordan W Smoller
Journal:  Am J Psychiatry       Date:  2010-08-16       Impact factor: 18.112

4.  Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Authors:  P F Sullivan; D Lin; J-Y Tzeng; E van den Oord; D Perkins; T S Stroup; M Wagner; S Lee; F A Wright; F Zou; W Liu; A M Downing; J Lieberman; S L Close
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

5.  Distinct subtypes of myelitis in systemic lupus erythematosus.

Authors:  J Birnbaum; M Petri; R Thompson; I Izbudak; D Kerr
Journal:  Arthritis Rheum       Date:  2009-11

6.  The heritability of bipolar affective disorder and the genetic relationship to unipolar depression.

Authors:  Peter McGuffin; Fruhling Rijsdijk; Martin Andrew; Pak Sham; Randy Katz; Alastair Cardno
Journal:  Arch Gen Psychiatry       Date:  2003-05

Review 7.  Autism and autism spectrum disorders: diagnostic issues for the coming decade.

Authors:  Fred R Volkmar; Matthew State; Ami Klin
Journal:  J Child Psychol Psychiatry       Date:  2009-01       Impact factor: 8.982

8.  Dissecting the phenotype in genome-wide association studies of psychiatric illness.

Authors:  Nick Craddock; Kenneth Kendler; Michael Neale; John Nurnberger; Shaun Purcell; Marcella Rietschel; Roy Perlis; Susan L Santangelo; Thomas G Schulze; Thomas Schulze; Jordan W Smoller; Anita Thapar
Journal:  Br J Psychiatry       Date:  2009-08       Impact factor: 9.319

9.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study.

Authors:  Paul Lichtenstein; Benjamin H Yip; Camilla Björk; Yudi Pawitan; Tyrone D Cannon; Patrick F Sullivan; Christina M Hultman
Journal:  Lancet       Date:  2009-01-17       Impact factor: 79.321

10.  Risk factors and subtype analysis of acute ischemic stroke.

Authors:  Shiao-Lin Lai; Hsu-Huei Weng; Meng Lee; Ming-Chang Hsiao; Leng-Jye Lin; Weng-Yi Huang
Journal:  Eur Neurol       Date:  2008-08-29       Impact factor: 1.710

View more
  16 in total

1.  A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits.

Authors:  Samsiddhi Bhattacharjee; Preetha Rajaraman; Kevin B Jacobs; William A Wheeler; Beatrice S Melin; Patricia Hartge; Meredith Yeager; Charles C Chung; Stephen J Chanock; Nilanjan Chatterjee
Journal:  Am J Hum Genet       Date:  2012-05-04       Impact factor: 11.025

2.  Identification of 16q21 as a modifier of nonsyndromic orofacial cleft phenotypes.

Authors:  Jenna C Carlson; Jennifer Standley; Aline Petrin; John R Shaffer; Azeez Butali; Carmen J Buxó; Eduardo Castilla; Kaare Christensen; Frederic W-D Deleyiannis; Jacqueline T Hecht; L Leigh Field; Ariuntuul Garidkhuu; Lina M Moreno Uribe; Natsume Nagato; Ieda M Orioli; Carmencita Padilla; Fernando Poletta; Satoshi Suzuki; Alexandre R Vieira; George L Wehby; Seth M Weinberg; Terri H Beaty; Eleanor Feingold; Jeffrey C Murray; Mary L Marazita; Elizabeth J Leslie
Journal:  Genet Epidemiol       Date:  2017-11-10       Impact factor: 2.135

3.  Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.

Authors:  Jie Huang; Roy H Perlis; Phil H Lee; A John Rush; Maurizio Fava; Gary S Sachs; Jeffrey Lieberman; Steven P Hamilton; Patrick Sullivan; Pamela Sklar; Shaun Purcell; Jordan W Smoller
Journal:  Am J Psychiatry       Date:  2010-08-16       Impact factor: 18.112

4.  Semiparametric Allelic Tests for Mapping Multiple Phenotypes: Binomial Regression and Mahalanobis Distance.

Authors:  Arunabha Majumdar; John S Witte; Saurabh Ghosh
Journal:  Genet Epidemiol       Date:  2015-10-23       Impact factor: 2.135

Review 5.  Coordinating GWAS results with gene expression in a systems immunologic paradigm in autoimmunity.

Authors:  Barbara E Stranger; Phillip L De Jager
Journal:  Curr Opin Immunol       Date:  2012-10-03       Impact factor: 7.486

6.  A multiclass likelihood ratio approach for genetic risk prediction allowing for phenotypic heterogeneity.

Authors:  Yalu Wen; Qing Lu
Journal:  Genet Epidemiol       Date:  2013-08-11       Impact factor: 2.135

Review 7.  Pleiotropy in complex traits: challenges and strategies.

Authors:  Nadia Solovieff; Chris Cotsapas; Phil H Lee; Shaun M Purcell; Jordan W Smoller
Journal:  Nat Rev Genet       Date:  2013-06-11       Impact factor: 53.242

8.  Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness.

Authors:  Tim B Bigdeli; Stephan Ripke; Silviu-Alin Bacanu; Sang Hong Lee; Naomi R Wray; Pablo V Gejman; Marcella Rietschel; Sven Cichon; David St Clair; Aiden Corvin; George Kirov; Andrew McQuillin; Hugh Gurling; Dan Rujescu; Ole A Andreassen; Thomas Werge; Douglas H R Blackwood; Carlos N Pato; Michele T Pato; Anil K Malhotra; Michael C O'Donovan; Kenneth S Kendler; Ayman H Fanous
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-12-11       Impact factor: 3.568

9.  Selectivity in genetic association with sub-classified migraine in women.

Authors:  Daniel I Chasman; Verneri Anttila; Julie E Buring; Paul M Ridker; Markus Schürks; Tobias Kurth
Journal:  PLoS Genet       Date:  2014-05-22       Impact factor: 5.917

10.  Postgwas: advanced GWAS interpretation in R.

Authors:  Milan Hiersche; Frank Rühle; Monika Stoll
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.